T cell epitope-containing peptides of the major dog allergen can f 1 as candidates for allergen immunotherapy

被引:30
作者
Immonen, A
Farci, S
Taivainen, A
Partanen, J
Pouvelle-Moratille, S
Närvänen, A
Kinnunen, T
Saarelainen, S
Rytkönen-Nissinen, M
Maillere, B
Virtanen, T
机构
[1] Univ Kuopio, Dept Clin Microbiol, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Chem, FIN-70211 Kuopio, Finland
[3] Comis Nacl Energia Atom, Dept Ingn & Etudes Prot, Gif Sur Yvette, France
[4] Kuopio Univ Hosp, Dept Pulm Dis, SF-70210 Kuopio, Finland
[5] Finnish Red Cross & Blood Transfus Serv, Dept Tissue Typing, SF-00310 Helsinki, Finland
关键词
D O I
10.4049/jimmunol.175.6.3614
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One prerequisite for developing peptide-based allergen immunotherapy is knowing the T cell epitopes of an allergen. In this study, human T cell reactivity against the major dog allergen Can f I was investigated to determine peptides suitable for immunotherapy. Seven T cell epitope regions (A-G) were found in Can 11 with specific T cell lines and clones. The localization of the epitope regions shows similarities with those of the epitopes found in Bos d 2 and Rat n 1. On average, individuals recognized three epitopes in Can f 1. Our results suggest that seven 16-mer peptides (p15-30, p33-48, p49-64, p73-88, p107-122, p123-138, and p141-156), each from one of the epitope regions, show widespread T cell reactivity in the population studied, and they bind efficiently to seven HLA-DRB1 molecules (DRB1*0101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1101, DRB1*1301, and DRB1*1501) predominant in Caucasian populations. Therefore, these peptides are potential candidates for immunotherapy of dog allergy.
引用
收藏
页码:3614 / 3620
页数:7
相关论文
共 54 条
[1]   Allergen immunotherapy: Therapeutic vaccines for allergic diseases - A WHO position paper [J].
Bousquet, J ;
Lockey, R ;
Malling, HJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :558-562
[2]   PERIPHERAL T-CELL TOLERANCE INDUCED IN NAIVE AND PRIMED MICE BY SUBCUTANEOUS INJECTION OF PEPTIDES FROM THE MAJOR CAT ALLERGEN FEL-D-I [J].
BRINER, TJ ;
KUO, MC ;
KEATING, KM ;
ROGERS, BL ;
GREENSTEIN, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7608-7612
[3]   The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ T cells [J].
Brogdon, JL ;
Leitenberg, D ;
Bottomly, K .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3825-3832
[4]  
CARBALLIDO JM, 1993, J IMMUNOL, V150, P3582
[5]  
Cárdaba B, 1998, CLIN EXP ALLERGY, V28, P413
[6]  
Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928
[7]  
Charron D., 1997, GENETIC DIVERSITY HL, P665
[8]   Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat [J].
Counsell, CM ;
Bond, JF ;
Ohman, JL ;
Greenstein, JL ;
Garman, RD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (05) :884-894
[9]  
de Lalla C, 1999, J IMMUNOL, V163, P1725
[10]  
DEMOTZ S, 1989, J IMMUNOL, V143, P3881